5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of NNMT, an enzyme found mainly in fat and liver cells. Blocking NNMT raised NAD+ in fat cells and, in diet-induced obese mice, reduced body weight, fat mass and cholesterol without the mice eating less. That is why it is sold for weight loss. But it has never been tested in a human trial: ClinicalTrials.gov lists none, so its benefits, dose and side effects in people are unknown.

Despite how it is often described, 5-amino-1MQ is not a peptide and not a natural compound; it is a lab-made quinolinium molecule. This page merges our two older 5-amino-1MQ guides.

The Science Behind 5-Amino 1MQ

The Science Behind 5-Amino 1MQ

Nicotinamide N-methyltransferase (NNMT) is an enzyme found in various cells throughout the body, with higher concentrations in the liver and fat cells. Studies, primarily in mice, have indicated a connection between high levels of NNMT and lower levels of the sugar transporter GLUT4. GLUT4 plays a crucial role in regulating blood sugar levels and is predominantly found in muscle and fat cells. In essence, GLUT4 helps transport sugar from the bloodstream into cells for energy.

Exercise is known to stimulate GLUT4 production, which is one reason it aids in weight management and blood sugar control.

That link, first described in mouse studies, made NNMT a target for obesity and diabetes research.

In animal models, high levels of NNMT in fat cells have been observed in those with insulin resistance. Manipulating this enzyme may help prevent insulin resistance and, consequently, type 2 diabetes, while also impacting weight gain and obesity.

Human metabolism is incredibly efficient, designed to make the most of available calories.

However, this efficiency can unfortunately contribute to weight gain when calorie intake is excessive. The long-sought goal in medicine has been to reduce this metabolic efficiency, essentially encouraging the body to “waste” calories, to combat the growing obesity epidemic. Scientists believe they may have found a crucial link in NNMT and its interaction with GLUT4.

Simply put, NNMT can slow down the rate at which the body uses calories, leading to their storage as fat or glycogen. When NNMT levels are reduced, for example, by a compound like 5-amino-1MQ, the body’s energy burning may increase, and energy storage may decrease.

This, combined with the potential for lower NNMT levels to enhance GLUT4 transporter expression, could lead to improved glucose clearance from the bloodstream and more efficient glucose utilization. This process may reduce insulin requirements, decrease insulin resistance, limit fat formation, and boost overall energy metabolism.

In the key 2018 mouse study, diet-induced obese mice treated with a potent NNMT inhibitor of this class lost body weight and white fat, had smaller fat cells and lower plasma cholesterol, and did not eat less. The researchers saw no observable adverse effects in the mice. In fat cells in the lab, the inhibitors raised NAD+ and reduced fat formation.

Recent research suggests that the benefits of 5-amino-1MQ extend beyond its ability to downregulate NNMT and improve metabolic efficiency and GLUT4 expression.

Studies in mice indicate that 5-amino-1MQ may alter how fat cells function by increasing GLUT4 expression, potentially leading to the production of a different class of lipids known as PAHSAs (palmitic acid esters of hydroxy-stearic acids).

PAHSAs have been shown to independently lower insulin resistance and inflammation, which could improve risk profiles for cardiovascular events like heart attack and stroke. While this aspect of 5-amino-1MQ is relatively new, it hints at a broader range of potential health benefits.

Furthermore, elevated NNMT expression is a common characteristic of muscle-wasting conditions such as Duchenne Muscular Dystrophy. Lowering NNMT levels may help alleviate some of these symptoms, possibly due to NNMT’s role in preventing stem cell proliferation and division.

Compounds like 5-amino-1MQ could potentially assist in managing various muscle-wasting disorders by reducing NNMT levels.

Another factor influencing muscle function appears to be NAD+ levels. NNMT inhibition leads to an increase in NAD+ levels. In animal models, compounds like 5-amino-1MQ have been reported to improve muscular function, cardiac health, and symptoms of DMD by replenishing NAD+ levels through NNMT inhibition.

These advantages seem to stem from improvements in mitochondrial function, coupled with reductions in inflammation and fibrosis, all of which are linked to increased NAD+ levels.

The effects of 5-amino-1MQ on skeletal muscle are multifaceted. Similar to its impact on adipose tissue, the presence of 5-amino-1MQ in muscle may enhance the synthesis of the GLUT4 receptor and increase metabolic inefficiency, leading to greater energy expenditure.

A recent mouse study also suggests that blocking NNMT, including with 5-amino-1MQ, could improve muscle healing by activating stem cells.

What has and hasn’t been studied

Claim Evidence
Fat loss and lower body weight Mice on a high-fat diet; no human data
Lower cholesterol Mice; no human data
Raises NAD+ Fat cells in the lab
Muscle repair and aging muscle Mouse studies
Energy, appetite, athletic performance Not studied
Safety in humans Unknown: no human trial

Who is interested in 5-amino-1MQ?

For individuals exploring comprehensive strategies to support metabolic health and potentially address age-related changes, 5-amino 1MQ may be a consideration. It has been observed to boost NAD+ levels, increase metabolic rate, and activate sirtuin-1 (SIRT1), often referred to as a “longevity gene.” Activation of SIRT1 has been associated with potential reductions in the risk of heart, liver, and kidney disease, metabolic syndrome, diabetes, obesity, neurodegeneration, and certain cancers. While promising, it’s important to consult with a healthcare professional to determine if 5 amino 1MQ is appropriate for your individual health needs.

Potential benefits (from animal research)

Potential Benefits of 5-Amino 1MQ

While more research, particularly in humans, is needed, scientists have identified several potential advantages associated with 5-amino 1MQ based on current studies:

  • Supports Fat Metabolism: It may help your body more effectively burn fat for energy.
  • Maintains Muscle Mass: Research suggests it could contribute to the preservation of muscle mass.
  • Potential for Obesity Management: It shows promise as a supportive option for preventing and potentially reversing obesity, particularly in animal models.
  • Metabolic Support for Type 2 Diabetes: It may offer a beneficial approach for individuals with type 2 diabetes or other obesity-related metabolic challenges.
  • Boosts Basal Metabolic Rate (BMR): By influencing an enzyme that regulates energy utilization, it may lead to an increase in your body’s resting energy expenditure.
  • Enhances Muscle Tissue: It could promote satellite cell formation and proliferation in muscle tissue, potentially improving athletic power and contractile ability.
  • May Lower Cholesterol Levels: Studies have indicated a potential for reduced cholesterol levels.
  • Increases Cellular Energy: It may enhance the energy production within cells.
  • Reduces Inflammation: Research suggests a role in decreasing inflammation.
  • Sustained NAD+ Levels: It contributes to increases in NAD+ levels, a molecule recognized for its role in cellular processes related to aging.

Other potential health benefits of 5-Amino-1MQ include improving symptoms of obesity-related metabolic disorders, boosting cellular energy-burning, preventing lipogenesis (fat formation), improving cognition, and increasing NAD+ concentrations in fat cells.

Side effects and safety

5 Amino 1MQ – Potential Side Effects and Safety Considerations (How to take 5

There are no published human safety data for 5-amino-1MQ. In the 2018 mouse study, no adverse effects were observed. Some sites, including an older version of this page, list serious side effects such as bone marrow failure, low platelets, Guillain-Barré syndrome and inflammation of the heart lining; we found no published report linking any of these to 5-amino-1MQ. The honest position is that side effects in people are unknown. Anyone with a medical condition, taking medication, or pregnant or breastfeeding should not use it without medical advice, because nothing is known about interactions.

Dosing

We do not give personal doses. There is no human dosing study. Products are sold as 50 mg capsules, and the “50 mg one to three times a day” schedule seen online is not based on any trial; animal doses do not translate to people.

Where to buy 5-amino-1MQ

Where to Learn More and Purchase 5-Amino 1MQ

Sarmguide’s pick is SwissChems, which sells 5-amino-1MQ as 50 mg capsules and publishes independent test results per batch. Check the certificate of analysis; see our lab tests guide.

Conclusion

5-Amino-1MQ is an interesting research compound: in obese mice, blocking NNMT reduced weight and fat without reducing food intake. It has never been tested in people, so claims about weight loss, energy or anti-ageing in humans are unproven, and its side effects in people are unknown. Related: NAD+ guide · peptides for weight loss · MOTS-c

Frequently asked questions

What is 5-amino-1MQ?

A lab-made NNMT blockerEvidence: Lab

A lab-made small molecule (5-amino-1-methylquinolinium) that blocks the enzyme NNMT. It is not a peptide and not naturally occurring.

Read the full section

Does 5-amino-1MQ help with weight loss?

In mice onlyEvidence: Animal

In diet-induced obese mice, NNMT inhibitors of this type reduced body weight and fat mass without changing food intake. It has never been tested for weight loss in people.

Is 5-amino-1MQ safe?

Unknown in peopleEvidence: Limited

There are no human trials, so its safety in people is unknown. No adverse effects were observed in the key mouse study.

Read the full section

What are the side effects of 5-amino-1MQ?

Unknown in humansEvidence: Limited

There are no published human safety data. Serious side-effect lists seen online are not backed by any published report on 5-amino-1MQ.

Read the full section

What does 5-amino-1MQ do?

Blocks the enzyme NNMTEvidence: Animal

Blocking NNMT raised NAD+ and reduced fat formation in lab fat cells. In mice it lowered fat mass and cholesterol.

Read the full section

Are there drug interactions with 5-amino-1MQ?

Not studiedEvidence: Limited

Nothing is known about interactions. Anyone with a medical condition, taking medication, or pregnant or breastfeeding should not use it without medical advice.

Read the full section

How do you take 5-amino-1MQ?

No evidence-based doseEvidence: Limited

It is sold as oral 50 mg capsules, but there is no human dosing study. Schedules seen online are not based on any trial, and animal doses do not translate to people.

Read the full section

Has 5-amino-1MQ been tested in humans?

NoEvidence: Limited

ClinicalTrials.gov lists no registered studies of 5-amino-1MQ or NNMT inhibitors (checked 30 October 2026).

Sources

  1. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice 2018 · PMID 29155147
  2. Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice 2022 · PMID 35013352
  3. ClinicalTrials.gov search for "5-amino-1MQ" and "NNMT inhibitor": no registered studies (checked 30 October 2026) 2026